The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La ...

"Roche has filed an appeal against the Hon. Delhi High Court order and the matter is subjudice in the appeal court," Roche ...

The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.

Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.

In what could be promising news for patients battling spinal muscular atrophy (SMA), the Delhi High Court has refused to ...

In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by ...

The Delhi High Court has observed that availability of a drug for treatment of rare diseases at economical and competitive ...

The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy ...

Shares of Indian pharmaceutical firms rose 3%-13% after Trump did not specify reciprocal tariffs for the sector. The ...

Roche had appealed against a single judge order of March 24 that had refused to stop Natco Pharma from manufacturing a generic version of Risdiplam ...

Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...

It’s a party for pharma stocks on Dalal Street. The Nifty Plarma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...